Foot Orthotic Insoles Market Report 2026

The foot orthotic insoles market size has grown strongly in recent years. It will grow from $4.08 billion in 2025 to $4.43 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prevalence of foot-related disorders, increasing awareness of corrective foot care, expansion of sports and fitness participation, growing elderly population, availability of over-the-counter orthotic solutions.

The foot orthotic insoles market size is expected to see strong growth in the next few years. It will grow to $6.02 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing adoption of personalized medical devices, rising demand for sports injury prevention solutions, expansion of online orthotic distribution channels, growing focus on preventive healthcare, technological advancements in foot scanning and modeling. Major trends in the forecast period include increasing adoption of 3d-printed customized insoles, rising demand for prescription-based orthotic solutions, growing use of advanced composite materials, expansion of sports-specific orthotic designs, enhanced focus on ergonomic foot support.

The increasing prevalence of diabetes is expected to drive the growth of the foot orthotic insoles market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels, which over time can cause serious damage to the heart, blood vessels, eyes, kidneys, and nervous system. Foot orthotic insoles are commonly used to manage diabetic foot complications, including conditions such as Charcot arthropathy and foot ulcers. As the number of people living with diabetes continues to rise, the demand for specialized foot orthotic insoles is expected to increase accordingly. For example, in May 2024, according to data released by the British Diabetic Association, a UK-based diabetes charity, nearly 4.4 million people in the UK were diagnosed with diabetes during 2022-23. Therefore, the growing prevalence of diabetes is contributing to the expansion of the foot orthotic insoles market.

Leading companies operating in the foot orthotic insoles market are concentrating on advanced solutions such as 3D-printed digital orthopedic products to replace conventional handcrafted insoles. A 3D-printed solution represents an efficient and sustainable approach that minimizes material waste while improving customization, comfort, and overall patient performance. For instance, in May 2024, Create it REAL, a Denmark-based 3D printing research and development center, launched a 3D Printing Service Platform for custom orthopedic products. This platform replaces traditional insole manufacturing by enabling the digital ordering of customized orthopedic items, including insoles, wheelchair seating, and corrective braces. The solution offers features such as variable stiffness, programmable foam-based pressure distribution, and biocompatible TPU materials, allowing orthopedic professionals to customize products easily without additional manual labor or excess material usage. Integrated with Create it REAL’s Embrace Suite and supported by local 3D printing hubs across Europe, the platform streamlines digital workflows, enhances patient comfort, simplifies production, and supports scalable personalized care.

In October 2025, Coats Group plc, a UK-based manufacturing company, acquired OrthoLite Holdings LLC for $770 million. Through this acquisition, Coats sought to strengthen its footwear division by expanding into the premium insole segment and enhancing its technological capabilities in sustainable and high-performance foot comfort solutions. OrthoLite Holdings LLC is a US-based manufacturer specializing in premium open-cell foam insoles for global footwear brands, supplying more than 550 brands and producing over 500 million pairs of insoles each year.

Major companies operating in the foot orthotic insoles market are Hanger Inc., Implus LLC, Footbalance Systems Ltd., Thuasne SAS, Foot Science International, Aetrex Worldwide Inc., Tynor Orthotics Pvt. Ltd., DJO Global Inc., Acor Orthopedic Inc., Algeo Limited, KLM Laboratories Inc., Arden Orthotics Ltd., Bauerfeind AG, ComfortFit Orthotic Labs Inc., Bolton Bros Limited, Superfeet Worldwide Inc., Birkenstock Orthopädie GmbH & Co. KG, Spenco Medical Corporation, SOLO Laboratories Inc., Foot Levelers Inc., Vasyli Medical, Ottobock SE & Co. KGaA, Össur hf Corp., Fillauer LLC, Cascade Dafo Inc., Allard USA Inc., ProLab Orthotics Ltd., SureFit Inc., Langer Biomechanics, Pedorthic Shoe Company.

North America was the largest region in the foot orthotic insoles market in 2025. The regions covered in the foot orthotic insoles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the foot orthotic insoles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The foot orthotic insoles market consists of sales of functional orthotics, accommodative orthotics, and semi-rigid orthotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.